Urinary Immunoglobulin G as A Parameter for Early Detection of Chronic Kidney Disease in Patients with Metabolic Syndrome | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 2, Issue 2, October 2022 PDF (663.25 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2022.455815 | ||
| Abstract | ||
| Both metabolic syndrome (MetS) and chronic kidney disease (CKD) are major global health issues and are major risk factors for all-cause death and cardiovascular death. Patients with MetS are at a significantly higher risk for CKD. Urinary IgG is an important marker protein for early glomerular damage and increased urinary IgG levels were found to be a useful predictor of diabetic kidney disease in normoalbuminuric patients. We aimed to assess urinary immunoglobulin G (IgG) levels as a predictor of early CKD in subjects with MetS. | ||
|
Statistics Article View: 30 PDF Download: 15 |
||
